NeoPhore is turning cold tumors hot by inhibiting DNA mismatch repair to produce more of the neoantigens that trigger immune attack.
![](https://o2hventures.com/wp-content/uploads/2020/08/Neophore1.png)
![](https://o2hventures.com/wp-content/uploads/2020/08/Neophore-3.png)
![](https://o2hventures.com/wp-content/uploads/2020/08/Neophore2.png)
Status | Active |
Website | https://www.neophore.com/ |
Category | Biotech |
Modality | Small Molecule |
Headquaters | Cambridge, UK |
Partner | Phoremost |
Investment Portfolio | Pre-Fund Investment |
Co-Investors | Parkwalk Sixth Element |